Lorenzini J L, Allain J P, Chalopin J M, Rifle G, Devilliers E, Carli P M, Cortet P, Bonhomme J
Nouv Rev Fr Hematol (1978). 1983;25(1):23-6.
The case of a 72 year-old man with a sinus histiocytosis is reported. The clinical course was characterised by an hemorrhagic disorder linked to a factor VIII inhibitor. The characteristics of the antibody titer, affinity and saturability have been studied. In an attempt to stop the bleeding treatment included human and porcine factor VIII concentrates, plasmapheresis and immunosuppressive drugs. Repeated plasma exchanges did not modify the inhibitor titer for more than 24 h.
报告了一例72岁患窦组织细胞增生症的男性病例。临床病程的特征为与VIII因子抑制剂相关的出血性疾病。已对抗体滴度、亲和力和饱和性的特征进行了研究。为了止血,治疗措施包括使用人源和猪源VIII因子浓缩物、血浆置换和免疫抑制药物。重复进行血浆置换在超过24小时的时间内并未改变抑制剂滴度。